Literature DB >> 27028260

Synthesis of some novel 2-substituted benzothiazole derivatives containing benzylamine moiety as monoamine oxidase inhibitory agents.

Betül Kaya1, Begüm Nurpelin Sağlık1,2, Serkan Levent1,2, Yusuf Özkay1,2, Zafer Asım Kaplancıklı1.   

Abstract

In the present work, 12 new 2-(5-substituted-benzothiazol-2-ylsulfanyl)-N-(substitutedbenzyl)-N-(4-substitutedphenyl) acetamide derivatives (4a-l) was designed and synthesized. The structures of the synthesized compounds were clarified using Fourier transform infrared spectroscopy (FTIR), proton nuclear magnetic resonance ((1)H-NMR), carbon-13 nuclear magnetic resonance ((13)C-NMR) and high-resolution mass spectrometry (HRMS) spectral data. Purity of synthesized compounds was checked by high-performance liquid chromatography (HPLC) analyses and purity ratio was found between 96.5-99.9%. The inhibitory activity of the compounds against MAO-A and MAO-B enzymes was evaluated by using in vitro flurometric method in which kynuramine was used as a substrate. Most of the compounds exhibited more selective inhibitory activity towards monoamine oxidase B (MAO-B) than monoamine oxidase A (MAO-A). Compound 4h was determined as the most potent compound against both enzyme types. The MAO-B enzyme kinetic of the compound 4h was studied and nature of MAO-B inhibition, caused by this compound, was investigated. The graphical analysis of steady-state inhibition data indicated that compound 4h is a mixed type inhibitor. Theoretical calculation of absorption, distribution, metabolism, excretion (ADME) properties for the synthesized compounds was also carried out and observed data supported the potential of compound 4h.

Entities:  

Keywords:  Benzothiazole; MAO-A; MAO-B; kynuramine

Mesh:

Substances:

Year:  2016        PMID: 27028260     DOI: 10.3109/14756366.2016.1161621

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  6 in total

1.  Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.

Authors:  Sinem Ilgın; Derya Osmaniye; Serkan Levent; Begüm Nurpelin Sağlık; Ulviye Acar Çevik; Betül Kaya Çavuşoğlu; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2017-12-09       Impact factor: 4.411

2.  Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.

Authors:  Betül Kaya; Leyla Yurttaş; Begüm Nurpelin Sağlik; Serkan Levent; Yusuf Özkay; Zafer Asim Kaplancikli
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents.

Authors:  Betül Kaya Çavuşoğlu; Begüm Nurpelin Sağlık; Derya Osmaniye; Serkan Levent; Ulviye Acar Çevik; Abdullah Burak Karaduman; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2017-12-28       Impact factor: 4.411

4.  Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors.

Authors:  Begüm Nurpelin Sağlık; Derya Osmaniye; Ulviye Acar Çevik; Serkan Levent; Betül Kaya Çavuşoğlu; Özlem Atlı Eklioğlu; Yusuf Özkay; Ali Savaş Koparal; Zafer Asım Kaplancıklı
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

5.  Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling.

Authors:  Begüm Nurpelin Sağlık; Betül Kaya Çavuşoğlu; Ulviye Acar Çevik; Derya Osmaniye; Serkan Levent; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  RSC Med Chem       Date:  2020-08-18

6.  Synthesis and Antidepressant Activity Profile of Some Novel Benzothiazole Derivatives.

Authors:  Ümide Demir Özkay; Ceren Kaya; Ulviye Acar Çevik; Özgür Devrim Can
Journal:  Molecules       Date:  2017-09-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.